← Leaderboards
Gary Lee Francis
Cleveland Clinic Lerner Com-Cwru
$1,446,775
Attributed
$1,446,775
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $380.1K · FY2006–10$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,446,775 · 12
By mechanism
P50$1,186,599 · 1
M01$260,176 · 11
Top collaborators
No co-investigators on record.
Most similar at Cleveland Clinic Lerner Com-Cwru
Same institution · by research overlap
- Emilio Daniel Poggio$3,940,852
- Matthew Douglas Johnson$14,345,464
- John F O'Toole$5,821,442
- John R. Sedor$11,687,749
- Jaroslaw P Maciejewski$28,244,801
Others in their field
Top investigators on “Grant”
- David R. Weir · University Of Michigan At Ann Arbor$373,949,788
- David Heimbrook · Leidos Biomedical Research, Inc.$341,196,902
- Eric S Lander · Whitehead Institute For Biomedical Res$323,181,457
- Jeffrey P Krischer · University Of South Florida$258,583,867
- Lawrence Corey · Fred Hutchinson Cancer Center$253,286,867
- Barton F Haynes · Duke University$243,251,908
Research focus
GrantComputer Retrieval Of Information On Scientific Projects DatabaseSourceInstitutionUnited States National Institutes Of HealthResourcesFundingResearch PersonnelAdolescentInsulinImmune ToleranceClinical ResearchMetabolicDatabasesGeneticDesignRecruitment ActivityFutureImmunologicsAutoantibodiesAntigensDiabetes PreventionBeta CellCharacteristics
Grant awards (16)
CLINICAL RESEARCH INFRASTRUCTURE$259,814
P50 · FY2010 · HL · contact PI
BARRIERS TO EFFECTIVE WEIGHT LOSS IN OVERWEIGHT ADOLESCENTS ENROLLED IN AN IN$39,140
M01 · FY2010 · RR · contact PI
ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABE$1,127
M01 · FY2010 · RR · contact PI
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$966
M01 · FY2010 · RR · contact PI
CLINICAL RESEARCH INFRASTRUCTURE$252,745
P50 · FY2009 · HL · contact PI
BARRIERS TO EFFECTIVE WEIGHT LOSS IN OVERWEIGHT ADOLESCENTS ENROLLED IN AN IN$104,037
M01 · FY2009 · RR · contact PI
UNDERSTANDING THE BARRIERS IN TREATMENT OF OBESITY IN ADOLESCENTS IN CENTRAL VA-$17,261
M01 · FY2009 · RR · contact PI
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$4,199
M01 · FY2009 · RR · contact PI
ORAL INSULIN FOR PREVENTION OF DIABETES IN RELATIVES AT RISK FOR TYPE 1 DIABE$1,866
M01 · FY2009 · RR · contact PI
CLINICAL RESEARCH INFRASTRUCTURE$240,963
P50 · FY2008 · HL · contact PI
UNDERSTANDING THE BARRIERS IN TREATMENT OF OBESITY IN ADOLESCENTS IN CENTRAL VA-$42,475
M01 · FY2008 · RR · contact PI
TRIALNET NATURAL HISTORY STUDY OF THE DEVELOPMENT OF TYPE 1 DIABETES$7,964
M01 · FY2008 · RR · contact PI
BARRIERS TO EFFECTIVE WEIGHT LOSS IN OVERWEIGHT ADOLESCENTS ENROLLED IN AN IN$759
M01 · FY2008 · RR · contact PI
CLINICAL RESEARCH INFRASTRUCTURE$239,207
P50 · FY2007 · HL · contact PI
UNDERSTANDING THE BARRIERS IN TREATMENT OF OBESITY IN ADOLESCENTS IN CENTRAL VA-$40,382
M01 · FY2007 · RR · contact PI
CLINICAL RESEARCH INFRASTRUCTURE$193,870
P50 · FY2006 · HL · contact PI